DICON provides sophisticated data analysis and metrics, access to experts in infection control, opportunities to share successful programs, and extensive educational initiatives related to infection prevention.
Several members of the DICON team worked together under the leadership of Dr. Jessica Seidelman, MD, MPH to explore the potential impact of inconsistent methods for calculating SSI denominators when reporting SSI events to the National Health Safety Network. The full report can be viewed here.
DICON founder Dr. Dan Sexton provided editorial commentary for The Journal of Infectious Diseases that can be read in full here.
On May 17, 2019 the Centers for Disease Control and the National Tuberculosis Controllers Association published new recommendations on screening, testing, and treatment of tuberculosis in the U.S. The full publication can be found on the CDC website, or downloaded here.
Bacterial community composition and presence of antibiotic resistance genes (mecA, tetK, and vanA) on personal mobile devices (PMDs) of nurses in intensive care units (ICUs) were evaluated. Antibiotic resistance genes on PMDs decreased at the end of the shift, and a several microbial genera changed.
DICON physician, Dr. Deverick Anderson, worked with the ICU staff at Duke University Medical Center. Recruitment of 32 total volunteers was performed at a surgical ICU (SICU) and a medical ICU (MICU). In total, 31 volunteers completed the study.
During the past 18 years DICON has provided epidemiological data and support to more than 40 hospitals in 6 states while simultaneously learning a great deal about the challenges and opportunities for infection prevention in community hospitals.
DICON has been a long-term and valuable partner with my hospitals and me in our joint efforts to prevent hospital-acquired infections and improve patient safety.
